Clomiphene QB
Related Articles
As the 5th China International Import Expo prepares to open in just 30 days, more exhibits have been unveiled, some of which are making their global debut.
The consumer products section of the exhibition will also showcase many new and innovative hair products.
L’Oréal will present Colorsonic, a wearable device with a customizable design for precise coloring, already awarded at the International Consumer Electronics Show 2022, and which will make its debut in Asia at the 5th CIIE.
The oscillating brush head of the device can apply the dye evenly to the hair when moved along a zigzag path, giving consumers a stable coloring effect at home and avoiding the hassle of rubbing the dye everywhere.
Hoyu Group, which will attend the CIIE for the first time this year, will bring its famous hair color brands including Bigen and CIELO. This is the first offline exhibition they have attended in China.
Kao Corporation, an “old friend” of the exhibition, which has been present for five consecutive years, will bring its Liese bubble hair color products with new colors to this year’s exhibition. This series of products will be available online simultaneously.
In the medical equipment and healthcare section of the show, there will also be many “loyal” exhibitors.
World-leading biopharmaceutical company MSD said it will continue to attend the next CIIE this year, which coincides with the 30th anniversary of MSD’s entry into China.
A hand-drawn sketch of the MSD booth at the 5th CIIE. The MSD China Pavilion will feature a series of innovative exhibits and interactive experiences that will showcase the company’s centuries-old history, its outstanding achievements in the country over the past three decades, and its remarkable journey of growth alongside the thriving Chinese healthcare industry.
“Over the past five years, MSD has had the privilege of participating in the CIIE and witnessing China’s growing openness and partnership with the world,” said Anna Van Acker, senior vice president of MSD and President of MSD in China.
“With the CIIE’s world-class open platform, we look forward to continuing to deliver on MSD’s century-old promise to ‘Invent for Life’ as we strengthen our cooperation with public organizations, medical institutions, industrial partners and other sectors of society.”
This year will be MSD’s fourth participation in the CIIE. The main exhibition area is based on this year’s theme “30 Years of MSD in China: Writing Our Future, Healthcare for All”, and the featured exhibition of MSD – the oral antiviral drug used to treat COVID-19, molnupiravir – will be unveiled on this occasion. CIIE of the Year.
Johnson & Johnson will have a double stand covering a total area of over 1,100 square meters, making it one of the largest exhibits in Hall 7.2.
This year, the company will present nearly 200 innovative products from its three main business sectors: medical technology, pharmaceuticals and consumer healthcare.
Among the exhibits, approximately 40 will make their world or China premieres, bringing innovative global medical trends and cutting-edge solutions for a wide range of high-incidence conditions, including cardiovascular disease, high-incidence oncology, orthopedics, mental illness and cataracts.
It should be noted that its world-first exhibits include a paliperidone palmitate injection product, which is the world’s first and only drug to effectively treat schizophrenic patients with two injections per year.
